Killer T cells, glioblastoma, and microglia (IMAGE)
Caption
Anti-CTLA-4 therapy induces immune system's killer T cells (cyan) to infiltrate glioblastoma (green) and promote an anti-tumor partnership with brain-resident immune cells called microglia (magenta).
Credit
Salk Institute
Usage Restrictions
With credit and related coverage
License
Original content